Tirzepatide / B12
Tirzepatide is a dual-action metabolic peptide that works on both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This combined mechanism enhances appetite regulation, blood sugar control, and insulin sensitivity more robustly than GLP-1 therapy alone (like Semglutide, also known as Ozempic). Tirzepatide supports sustainable weight loss, metabolic health, and improved energy regulation. Tirzepatide is compounded with vitamin B12 to support energy and nutrient balance, though its primary effects come from its powerful metabolic signaling.




Select Size:
Tirzepatide offers broad metabolic benefits and is often chosen for patients who need deeper support with insulin resistance, appetite regulation, or weight loss. Potential benefits may include:
- Supports significant and sustainable weight loss by reducing appetite and increasing satiety
- Improves blood sugar regulation and insulin sensitivity, particularly in insulin resistance and metabolic syndrome
- Helps reduce cravings and compulsive eating behaviors, including sugar and binge-eating patterns
- Promotes healthier fat metabolism and body composition, especially when paired with adequate protein and movement
- Supports cardiovascular health by improving metabolic markers and reducing inflammation
- Helps stabilize energy levels and mood by minimizing blood sugar swings
- May provide metabolic, hormonal, and longevity benefits even at lower, maintenance-focused doses
- Pregnancy or Breastfeeding: Safety has not been established; use is not recommended.
- Personal or Family History of Medullary Thyroid Carcinoma: GLP-1/GIP therapies are contraindicated.
- Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2): Increased risk of thyroid tumors.
- History of Pancreatitis or Severe Gastrointestinal Conditions (e.g., gastroparesis): Use only with provider guidance and careful monitoring.
- Known Allergy: Avoid use if you have a sensitivity to Tirzepatide, B12, or formulation components.
Tirzepatide is generally well tolerated when used under medical supervision. Short-term side effects may occur, particularly when first starting or adjusting dose, including:
- Nausea (most common), especially during early treatment or dose increases
- Diarrhea or loose stools
- Constipation as digestion slows
- Decreased appetite, which may feel more pronounced early on
- Mild fatigue or headache as blood sugar and metabolic signaling adjust
- Temporary redness, tenderness, or itching at the injection site
These effects are typically mild and improve as the body adapts. At Extension Health, we emphasize starting at a low dose and increasing gradually, as this approach significantly reduces side effects and allows your body to adjust at a sustainable pace.
Regular provider check-ins are encouraged to assess tolerance, symptom response, and overall progress. Monitoring tools such as DEXA scans and bloodwork may be used to ensure adequate nutrition, preserve lean muscle mass, and support long-term metabolic health. Maintaining proper hydration and adequate protein intake while on a GLP-1/GIP therapy, and incorporating supportive peptides (such as growth hormone options) or vitamins when appropriate, can further help optimize muscle preservation and body composition.
For safe and informed use, review the Extension Health Injection Reaction Guide (PDF), which outlines what to expect, how to reduce discomfort, and when to seek medical support.
- Days 1–7: Tirzepatide begins activating both GLP-1 and GIP receptors, which regulate appetite, satiety, blood sugar, and insulin signaling. Early effects often include reduced hunger, feeling full sooner, and fewer cravings. Weight changes are usually minimal at this stage as the body adjusts to new metabolic signals.
- Weeks 2–4: As dual GLP-1/GIP signaling stabilizes, appetite regulation becomes more consistent and energy levels often feel steadier. Many patients notice improved portion control, reduced cravings (especially for sugar or late-night snacking), and better blood sugar stability. This is typically when gradual, sustainable weight loss begins for those using Tirzepatide for weight management..
- Weeks 4–8 and Beyond: With continued, individualized use, patients may experience steady improvements in weight, insulin sensitivity, metabolic health, and inflammation. At Extension Health, we generally recommend aiming for 1–2 pounds of weight loss per week, as this pace supports fat loss while preserving muscle mass and metabolic health.
Importantly, everyone’s ideal dose is different. Some patients gradually increase dosing to support weight loss goals, while others remain at lower or micro-dose levels long-term to support metabolic health, inflammation reduction, hormone balance, and longevity, without significant weight loss. Tirzepatide’s dual mechanism makes it highly adaptable across a wide range of health goals when used thoughtfully and under provider guidance.